Liver Disease Clinical Trials in Missouri

32 recruiting studies across 1 city

Browse by City

All Trials in Missouri

Phase

Trial	Phase	Sponsor	Dist.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
Integrated Cancer Repository for Cancer Research	—	University of Nebraska	<1 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	<1 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor	Phase 1/2	Eisai Inc.	<1 mi
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease	Phase 1	Children's Mercy Hospital Kansas City	<1 mi
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )	Phase 3	Inventiva Pharma	<1 mi
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment	—	Ipsen	<1 mi
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection	Phase 2	Gilead Sciences	<1 mi
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome	Phase 3	Albireo, an Ipsen Company	<1 mi
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)	Phase 2	Altimmune, Inc.	<1 mi
TReatment for ImmUne Mediated PathopHysiology	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	<1 mi
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)	—	Mirum Pharmaceuticals, Inc.	<1 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	<1 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Phase 3	Boehringer Ingelheim	<1 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Phase 3	Boehringer Ingelheim	<1 mi
Liver Adiposity Effects on Pediatric Statin	Phase 1	Children's Mercy Hospital Kansas City	<1 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	<1 mi
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis	Phase 3	Ipsen	3 mi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH	Phase 3	89bio, Inc.	3 mi
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC	N/A	University of Kansas Medical Center	3 mi
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma	Phase 2	Coherus Oncology, Inc.	3 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer	Phase 2	AstraZeneca	3 mi
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)	Phase 2	Deciphera Pharmaceuticals, LLC	5 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations	Phase 1	Tyra Biosciences, Inc	5 mi
T-Cell Therapy (ECT204) in Adults With Advanced HCC	Phase 1/2	Eureka Therapeutics Inc.	5 mi
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies	Phase 1/2	Anwaar Saeed	5 mi
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease	Phase 2	Delcath Systems Inc.	6 mi
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)	Phase 2/3	AbbVie	8 mi
PREHEVBRIO Pregnancy Outcomes Registry	—	VBI Vaccines Inc.	10 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection	Phase 1	GigaGen, Inc.	13 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.